with Neutrogena regaining its position as the top face care brand in the U.S. Filippo Falorni, Citi: Asked about Q1 2025 sales drag from pediatric pain and China distribution issues. CEO Mongon ...

(Bloomberg) -- For one executive, the clearest sign that Neutrogena had lost its way came when their daughter started buying ...

Dan Loeb’s Third Point Capital has built a stake in Tylenol and Neutrogena maker Kenvue, becoming the third activist hedge fund to target the $43bn consumer health group in recent months ...